Telepharmacy service experience during the COVID-19 pandemic in the Republic of Srpska, Bosnia and Herzegovina. 2022

Milena Kovačević, and Milica Ćulafić, and Sandra Vezmar Kovačević, and Slavenka Borjanić, and Branka Keleč, and Branislava Miljković, and Rada Amidžić
Department of Pharmacokinetics and Clinical Pharmacy, University of Belgrade - Faculty of Pharmacy, Belgrade, Serbia.

The COVID-19 pandemic exerted a profound impact on health systems worldwide. Moreover, significant concerns were raised in terms of middle- and long-term consequences of postponing care in non-COVID patients. The primary aim of the study was to describe the remote pharmaceutical care service (telepharmacy) during the COVID-19 pandemic in the Republic of Srpska (RS), Bosnia and Herzegovina. The secondary aim was to identify service users' needs and concerns and to describe community pharmacists' interventions. Ten community pharmacists were appointed by the Pharmaceutical Society of the RS to deliver telepharmacy services. After obtaining users' verbal permission, pharmacists documented issues discussed with them. The prospective data collection included the period from April 13 to May 21, 2020. Descriptive and statistical analysis was performed using IBM SPSS Statistics software (ver. 22). A total of 71 service users' charts were analyzed. Telepharmacy users were on average 61.31 ± 13.27 years of age, with almost equal gender distribution. Patients with chronic or acute/subacute conditions were predominant with a share of 84.5%. Chronic diseases were the main reason for searching pharmacists' consultation (74.6%), 7% had a complaint about worsening of a chronic condition, 9.9% reported only acute/subacute conditions as ambulatory conditions, whereas 15.5% asked information about coronavirus or COVID-19. The vast majority of patients' and users' needs were addressed by a pharmacist during counseling and only 15.5% of the patients required immediate referral to a doctor for refill/prescribing purposes. Remote pharmaceutical care service (telepharmacy) is deemed a convenient model in the RS during the COVID-19 pandemic. Patients and users presented with explicit and specific needs and concerns, both COVID- and non-COVID-related, which should not be neglected. Community pharmacists showed a high level of resilience and ability in addressing patients' needs.

UI MeSH Term Description Entries
D010595 Pharmacists Those persons legally qualified by education and training to engage in the practice of pharmacy. Clinical Pharmacists,Community Pharmacists,Retail Pharmacists,Clinical Pharmacist,Community Pharmacist,Pharmacist,Pharmacist, Clinical,Pharmacist, Community,Pharmacist, Retail,Pharmacists, Clinical,Pharmacists, Community,Pharmacists, Retail,Retail Pharmacist
D012017 Referral and Consultation The practice of sending a patient to another program or practitioner for services or advice which the referring source is not prepared to provide. Consultation,Gatekeepers, Health Service,Hospital Referral,Second Opinion,Consultation and Referral,Health Service Gatekeepers,Hospital Referrals,Referral,Referral, Hospital,Referrals, Hospital,Consultations,Gatekeeper, Health Service,Health Service Gatekeeper,Opinion, Second,Opinions, Second,Referrals,Second Opinions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D017522 Bosnia and Herzegovina A country of eastern Europe, formerly the province of Bosnia in Yugoslavia, uniting with the province of Herzegovina to form the Republic of Bosnia and Herzegovina in 1946. It was created 7 April 1992 as a result of the division of Yugoslavia and recognized by the United States as an independent state. Bosnia takes is name from the river Bosna, in turn from the Indoeuropean root bhog, "current"; Herzegovina is from the Serbian herceg (duke) + -ov (the possessive) + -ina (country or territory). Bosnia and Hercegovina,Bosnia-Herzegovina,Bosnia
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic

Related Publications

Milena Kovačević, and Milica Ćulafić, and Sandra Vezmar Kovačević, and Slavenka Borjanić, and Branka Keleč, and Branislava Miljković, and Rada Amidžić
September 2022, Antibiotics (Basel, Switzerland),
Milena Kovačević, and Milica Ćulafić, and Sandra Vezmar Kovačević, and Slavenka Borjanić, and Branka Keleč, and Branislava Miljković, and Rada Amidžić
January 2023, Frontiers in neurology,
Milena Kovačević, and Milica Ćulafić, and Sandra Vezmar Kovačević, and Slavenka Borjanić, and Branka Keleč, and Branislava Miljković, and Rada Amidžić
July 2022, Medicina (Kaunas, Lithuania),
Milena Kovačević, and Milica Ćulafić, and Sandra Vezmar Kovačević, and Slavenka Borjanić, and Branka Keleč, and Branislava Miljković, and Rada Amidžić
January 2024, Materia socio-medica,
Milena Kovačević, and Milica Ćulafić, and Sandra Vezmar Kovačević, and Slavenka Borjanić, and Branka Keleč, and Branislava Miljković, and Rada Amidžić
January 2008, Radiation protection dosimetry,
Milena Kovačević, and Milica Ćulafić, and Sandra Vezmar Kovačević, and Slavenka Borjanić, and Branka Keleč, and Branislava Miljković, and Rada Amidžić
November 2023, Journal of global health,
Milena Kovačević, and Milica Ćulafić, and Sandra Vezmar Kovačević, and Slavenka Borjanić, and Branka Keleč, and Branislava Miljković, and Rada Amidžić
April 2009, Pharmacoepidemiology and drug safety,
Milena Kovačević, and Milica Ćulafić, and Sandra Vezmar Kovačević, and Slavenka Borjanić, and Branka Keleč, and Branislava Miljković, and Rada Amidžić
January 2023, Journal of public health research,
Milena Kovačević, and Milica Ćulafić, and Sandra Vezmar Kovačević, and Slavenka Borjanić, and Branka Keleč, and Branislava Miljković, and Rada Amidžić
April 2020, Biological trace element research,
Milena Kovačević, and Milica Ćulafić, and Sandra Vezmar Kovačević, and Slavenka Borjanić, and Branka Keleč, and Branislava Miljković, and Rada Amidžić
June 2022, Materia socio-medica,
Copied contents to your clipboard!